Sexually Transmitted DiseaseNCT07471412

Sexually Transmitted Infections in Migrant Women

A study testing education in people with Sexually Transmitted Disease, run by Kahramanmaras Sutcu Imam University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record

Search all trials

Trial summary

The main objective of this study is to evaluate the effect of structured sexual health education for immigrant women on their levels of sexual health self-efficacy and reproductive autonomy using a randomized controlled design. Read more about this study

Who is it for?: Ages 18 to 65 years, women onlyHealthy volunteers can take part
Conditions the study is for: Sexually Transmitted Disease
What is being tested?: education
Type of treatment: Lifestyle or therapy programme
Could I receive a placebo?: No, everyone receives an active treatment
How many people: 100 participants
Where: 1 siteTurkey (Türkiye)
Study dates: 1 Mar 2026to 1 Aug 2026
Phase: Interventional
Are there results?: None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

Ages 18 to 65 years
Women only
Healthy volunteers accepted
Adult, Older adult

Who may be able to join

To be eligible, applicants must:
Be 18 years of age or older,
Have immigrant status and reside in Turkey,
Be one of the women who applied to or benefited from the services of the

Who cannot join

Being under 18 years of age,
Refusal to give informed consent for participation in the study,
Having a serious cognitive impairment or psychiatric condition that may prevent regular participation in the training and data collection process,
Having a severe language barrier that prevents communication during the study process and that cannot be overcome with translation or written materials,

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site

Kahramanmaras Sutcu Imam University
Kahramanmaraş

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Sexual Health Self-Efficacy and Reproductive Autonomy in Migrant Women Through Sexual Transmission Infections A Randomized Controlled Study

Read the detailed description

Sexuality is a fundamental aspect of human life that encompasses biological, psychological, and social dimensions and is shaped by individuals' personality traits, life experiences, and social conditions. Sexual satisfaction and adjustment are related not only to physical processes but also to psychological well-being and interpersonal relationships. In this context, sexual self-efficacy-defined as an individual's belief in their ability to manage emotions and behaviors in sexual situations-plays an important role, while reproductive autonomy refers to the ability to freely decide whether and when to have children. Migrant women may be more vulnerable in these areas due to various social and structural barriers; therefore, efforts aimed at strengthening sexual health self-efficacy and reproductive autonomy are considered important.

Conditions: Sexually Transmitted Disease
Being tested: education
Medical subject headings: Sexually Transmitted Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

educationBehavioural
Training Sessions and Topics Session 1: Sexually Transmitted Infections and Women's Health Definition and types of STIs Symptoms and asymptomatic courses in women Relationship of STIs with reproductive health and HIV risk Transmission routes and the importance of testing Session 2: Sexual Health Self-Efficacy and Protective Behaviors The concept of sexual health self-efficacy Protection methods and correct condom use Seeking healthcare and requesting testing Communication with healthcare professionals Session 3: Reproductive Autonomy, Communication, and Rights Reproductive autonomy and decision-making Communication with partners and setting boundaries Confidentiality and consent in healthcare Coping with stigma

Study groups in NCT07471412
Study group	Role	What they receive
Experimental: experimental group	Experimental	Application Description: The experimental group will receive education on sexually transmitted diseases and will be administered reproductive autonomy and sexual self-efficacy scales. Receives: Behavioral: education
No Intervention: Control Group	No intervention	No intervention will be made in the control group.

What is being measured

The primary outcome is the main question the study is designed to answer.

The primary endpoint will be the difference in mean knowledge scores between baseline (pre-intervention) and post-intervention assessments.
1. Level of Knowledge Regarding Sexually Transmitted Infections (STIs): Participants' level of knowledge regarding STIs will be assessed using knowledge questions included in a data collection form prepared by the researchers. The measurement tool is a structured questionnaire. The unit of measurement is the number of correct answers, and the total score obtained indicates the level of knowledge about STIs. Higher scores indicate a higher level of knowledge.
2. Level of Sexual Self-Efficacy: Participants' level of sexual self-efficacy will be assessed using the Sexual Self-Efficacy Scale (SSES), developed by Humphreys and Kennett (2010) and adapted into Turkish by Çelik (2012). The scale is an 8-point Likert-type scale consisting of 5 items. The unit of measurement is the total scale score, and the score range is 5-40. Higher scores indicate a higher level of sexual self-efficacy.
Measured: Pre-intervention (week 0), post-intervention (week 8), and 3-month follow-up.

Secondary outcomes (1)

The primary endpoint will be the change in the mean RAS score between baseline (pre-intervention) and post-intervention assessments.
1. Level of Reproductive Autonomy: Participants' level of reproductive autonomy will be assessed using the scale developed by Upadhyay et al. The Reproductive Autonomy Scale (RAS), developed by (2014) and validated and proven reliable in Turkish by Dursun and Gözüyeşil (2023), will be used for evaluation. The scale consists of 14 items and three sub-dimensions (Decision Making, Coercion Avoidance, Communication). The unit of measurement is the scale score, which is calculated as the average score obtained by dividing the total score by the number of items. Higher scores indicate higher reproductive autonomy.
Measured: Immediately after the intervention is completed.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

1 Mar 20261 Aug 2026

First posted13 Mar 2026
Study start1 Mar 2026
Primary completion1 Mar 2026
Study completion1 Aug 2026

Resources

Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
Publications (6)Papers the sponsor has linked to this study.
Other trials for Sexually Transmitted DiseaseStudies of the same condition, open and under way.
What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design

Study type: Interventional
Phase: Phase N/A
Primary purpose: Supportive care
Allocation: Randomised
Intervention model: Parallel groups
Model description: education-centered randomized controlled experimental study
Masking: None (open label)
Enrolment: 100 participants (actual)

IDs, dates and publications

ClinicalTrials.gov ID: NCT07471412
Sponsor's protocol ID: KahramanmarasSIUniversity
Other IDs: KahramanmarasSIUniversity
Status last verified: Mar 2026
First submitted: 9 Mar 2026
Last updated: 13 Aug 2026
Results posted: No
Data monitoring committee: No
FDA-regulated drug: No
FDA-regulated device: No
Individual data sharing: No: I do not approve of sharing ipd

Publications

Sadock, V. A. (1989). Psychosexual dysfunctions and treatment. In H. I. Kaplan & B. J. Sadock (Eds.), Comprehensive textbook of psychiatry (5th ed.). Baltimore, MD: Williams & Wilkins.
Reissing, E. D., Laliberté, G. M., & Davis, H. J. (2005). Young women's sexual adjustment: The role of sexual self-schema, sexual self-efficacy, sexual aversion and body attitudes. The Canadian Journal of Human Sexuality, 14(3-4).
Grace KT, Anderson JC. Reproductive Coercion: A Systematic Review. Trauma Violence Abuse. 2018 Oct;19(4):371-390. doi: 10.1177/1524838016663935. Epub 2016 Aug 16.
PubMed 27535921
Eysenck, H. J. (1971). Hysterical personality and sexual adjustment, attitudes and behavior. Journal of Sex Research, 7, 274-281.
Creti L, Libman E. Cognitions and sexual expression in the aging. J Sex Marital Ther. 1989 Summer;15(2):83-101. doi: 10.1080/00926238908403814.
PubMed 2769776
Bailes, S., Creti, L., Fichten, C. S., Libman, E., Brender, W., & Amsel, R. (1998). Sexual self-efficacy scale for female functioning. In C. M. Davis, W. L. Yarber, R. Bauserman, G. Schreer, & S. L. Davis (Eds.), Handbook of sexuality-related measures (pp. 531-534). London, England: Sage.

Want to know more?

The sponsor has not listed a contact. The official record may have more details.

Talk to your doctor first and take this page with you. Only the study team can confirm whether you can join.

Questions to ask the study team

What is the study trying to find out?
What would I need to do, and how often would I visit?
Could I receive a placebo instead of the treatment?
What are the possible risks and benefits for me?
Will it cost me anything? Are travel or time paid for?
Can I keep seeing my own doctor during the study?
What happens when the study ends?

See locations

Not yet recruiting
HIV/STI/HCV Testing and Overdose Prevention Among Survivors of Sex Trafficking
HIV Testing, STI
Active, not recruiting
Evaluating the Effectiveness of a Mobile HIV Prevention App to Increase HIV and Sexually Transmitted Infections (STI) Testing and PrEP Initiation Among Rural Men Who Have Sex With Men
HIV Infections, STI
Not yet recruiting
PNF RCT to Decrease Alcohol Use and Increase HIV Prevention
HIV (Human Immunodeficiency Virus), Alcohol Misuse
Not yet recruiting
Pilot HIV Self-Testing And Self-collected STI Testing Strategy for Sex Worker Empowerment Study
HIV, Syphilis
Recruiting
Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents
Sexually Transmitted Diseases

All Sexually Transmitted Disease trials

Study at a glance

From the registry record, last updated by the sponsor on 13 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.

Official title: The Effect of Sexual Health Self-Efficacy and Reproductive Autonomy in Migrant Women Through Sexual Transmission Infections A Randomized Controlled Study
ClinicalTrials.gov ID: NCT07471412
Acronym / sponsor ID: KahramanmarasSIUniversity
Conditions: Sexually Transmitted Disease
Study type: Interventional
Recruitment status: Completed
Enrolment: 100 participants (actual)
Lead sponsor: Kahramanmaras Sutcu Imam UniversityUniversity, hospital or other
Study start: 1 Mar 2026 (actual)
Primary completion: 1 Mar 2026 (actual)
Study completion: 1 Aug 2026 (actual)
First posted: 13 Mar 2026 (actual)
Results: Not posted in the source record

Clinical summary

The research question as the sponsor registered it. This describes what the study plans to test, not what it found.

Detailed description

Study design

Primary purpose: Supportive care
Allocation: Randomised
Intervention model: Parallel groups
Masking: None (open label)
Number of arms: 2
Model description: education-centered randomized controlled experimental study

Arm	Type	Receives
Experimental: experimental group	Experimental	Behavioral: educationApplication Description: The experimental group will receive education on sexually transmitted diseases and will be administered reproductive autonomy and sexual self-efficacy scales.
No Intervention: Control Group	No intervention	–No intervention will be made in the control group.

Who may qualify

Ages: 18 to 65 years
Sex: Female only
Healthy volunteers: Accepted
Age groups: Adult, Older adult

Key inclusion criteria (4 listed)

To be eligible, applicants must:
Be 18 years of age or older,
Have immigrant status and reside in Turkey,
Be one of the women who applied to or benefited from the services of the

Key exclusion criteria (4 listed)

Being under 18 years of age,
Refusal to give informed consent for participation in the study,
Having a serious cognitive impairment or psychiatric condition that may prevent regular participation in the training and data collection process,
Having a severe language barrier that prevents communication during the study process and that cannot be overcome with translation or written materials,

Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.

Interventions

Intervention	Type	Arms
educationTraining Sessions and Topics Session 1: Sexually Transmitted Infections and Women's Health Definition and types of STIs Symptoms and asymptomatic courses in women Relationship of STIs with reproductive health and HIV risk Transmission routes and the importance of testing Session 2: Sexual Health Self-Efficacy and Protective Behaviors The concept of sexual health self-efficacy Protection methods and correct condom use Seeking healthcare and requesting testing Communication with healthcare professionals Session 3: Reproductive Autonomy, Communication, and Rights Reproductive autonomy and decision-making Communication with partners and setting boundaries Confidentiality and consent in healthcare Coping with stigma	Behavioural	Experimental: experimental group

Primary outcome

The primary endpoint will be the difference in mean knowledge scores between baseline (pre-intervention) and post-intervention assessments.
Time frame: Pre-intervention (week 0), post-intervention (week 8), and 3-month follow-up.
1. Level of Knowledge Regarding Sexually Transmitted Infections (STIs): Participants' level of knowledge regarding STIs will be assessed using knowledge questions included in a data collection form prepared by the researchers. The measurement tool is a structured questionnaire. The unit of measurement is the number of correct answers, and the total score obtained indicates the level of knowledge about STIs. Higher scores indicate a higher level of knowledge. 2. Level of Sexual Self-Efficacy: Participants' level of sexual self-efficacy will be assessed using the Sexual Self-Efficacy Scale (SSES), developed by Humphreys and Kennett (2010) and adapted into Turkish by Çelik (2012). The scale is an 8-point Likert-type scale consisting of 5 items. The unit of measurement is the total scale score, and the score range is 5-40. Higher scores indicate a higher level of sexual self-efficacy.

1 secondary outcome

The primary endpoint will be the change in the mean RAS score between baseline (pre-intervention) and post-intervention assessments.
Time frame: Immediately after the intervention is completed.

Results and safety

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

Research links

Official record on ClinicalTrials.govLast updated by the sponsor 13 Aug 2026.
BackgroundSadock, V. A. (1989). Psychosexual dysfunctions and treatment. In H. I. Kaplan & B. J. Sadock (Eds.), Comprehensive textbook of psychiatry (5th ed.). Baltimore, MD: Williams & Wilkins.
BackgroundReissing, E. D., Laliberté, G. M., & Davis, H. J. (2005). Young women's sexual adjustment: The role of sexual self-schema, sexual self-efficacy, sexual aversion and body attitudes. The Canadian Journal of Human Sexuality, 14(3-4).
Background: PubMed 27535921Grace KT, Anderson JC. Reproductive Coercion: A Systematic Review. Trauma Violence Abuse. 2018 Oct;19(4):371-390. doi: 10.1177/1524838016663935. Epub 2016 Aug 16.
BackgroundEysenck, H. J. (1971). Hysterical personality and sexual adjustment, attitudes and behavior. Journal of Sex Research, 7, 274-281.
Background: PubMed 2769776Creti L, Libman E. Cognitions and sexual expression in the aging. J Sex Marital Ther. 1989 Summer;15(2):83-101. doi: 10.1080/00926238908403814.
BackgroundBailes, S., Creti, L., Fichten, C. S., Libman, E., Brender, W., & Amsel, R. (1998). Sexual self-efficacy scale for female functioning. In C. M. Davis, W. L. Yarber, R. Bauserman, G. Schreer, & S. L. Davis (Eds.), Handbook of sexuality-related measures (pp. 531-534). London, England: Sage.
Individual participant dataSharing planned: No. I do not approve of sharing ipd

Related trials for Sexually Transmitted Disease

Not yet recruiting
HIV/STI/HCV Testing and Overdose Prevention Among Survivors of Sex Trafficking
HIV Testing, STI
Active, not recruiting
Evaluating the Effectiveness of a Mobile HIV Prevention App to Increase HIV and Sexually Transmitted Infections (STI) Testing and PrEP Initiation Among Rural Men Who Have Sex With Men
HIV Infections, STI
Not yet recruiting
PNF RCT to Decrease Alcohol Use and Increase HIV Prevention
HIV (Human Immunodeficiency Virus), Alcohol Misuse
Not yet recruiting
Pilot HIV Self-Testing And Self-collected STI Testing Strategy for Sex Worker Empowerment Study
HIV, Syphilis
Recruiting
Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents
Sexually Transmitted Diseases

Referral and contact

AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.

The record lists no contact. Use the official record to reach the sponsor.

1 site in 1 country: see every site and its status.

Questions about this trial

What is this clinical trial studying?

A study testing education in people with Sexually Transmitted Disease, run by Kahramanmaras Sutcu Imam University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The primary endpoint will be the difference in mean knowledge scores between baseline (pre-intervention) and post-intervention assessments. (time frame: Pre-intervention (week 0), post-intervention (week 8), and 3-month follow-up.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07471412, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Aug 2026; AzTrials last refreshed its copy on 7 Nov 2026.